Our Ambition
Our Ambition
Build a global best-in-class beauty and wellness multi-brand platform by creating, acquiring, accelerating, and scaling the next generation of high-growth, purpose-driven brands.
Build a global best-in-class beauty and wellness multi-brand platform by creating, acquiring, accelerating, and scaling the next generation of high-growth, purpose-driven brands.
Latest News
View All
Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand
NASDAQ: -0.20 (-6.49%)
WALD $2.88